Sander JW - Search Results

1

No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy.

Lynch JM, Tate SK, Kinirons P, Weale ME, Cavalleri GL, Depondt C, Murphy K, O'Rourke D, Doherty CP, Shianna KV, Wood NW, Sander JW, Delanty N, Goldstein DB, Sisodiya SM. Lynch JM, et al. Among authors: sander jw. Epilepsy Res. 2009 Jan;83(1):44-51. doi: 10.1016/j.eplepsyres.2008.09.003. Epub 2008 Oct 31. Epilepsy Res. 2009. PMID: 18977120

2

Help-seeking strategies for epilepsy by previously untreated patients in northern Ecuador.

Farmer PJ, Placencia M, Jumbo L, Sander JW, Shorvon SD. Farmer PJ, et al. Among authors: sander jw. Epilepsy Res. 1992 May;11(3):205-13. doi: 10.1016/0920-1211(92)90100-8. Epilepsy Res. 1992. PMID: 1396536

3

An assessment of serum and red blood cell folate concentrations in patients with epilepsy on lamotrigine therapy.

Sander JW, Patsalos PN. Sander JW, et al. Epilepsy Res. 1992 Oct;13(1):89-92. doi: 10.1016/0920-1211(92)90011-h. Epilepsy Res. 1992. PMID: 1478201 Clinical Trial.

4

A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy.

Sander JW, Patsalos PN, Oxley JR, Hamilton MJ, Yuen WC. Sander JW, et al. Epilepsy Res. 1990 Aug;6(3):221-6. doi: 10.1016/0920-1211(90)90077-9. Epilepsy Res. 1990. PMID: 2272345 Clinical Trial.

5

The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsy.

Sander JW, Trevisol-Bittencourt PC, Hart YM, Patsalos PN, Shorvon SD. Sander JW, et al. Epilepsy Res. 1990 Dec;7(3):226-9. doi: 10.1016/0920-1211(90)90019-r. Epilepsy Res. 1990. PMID: 2289481

6

Nifedipine as an add-on drug in the management of refractory epilepsy.

Sander JW, Trevisol-Bittencourt PC. Sander JW, et al. Epilepsy Res. 1990 May-Jun;6(1):82-4. doi: 10.1016/0920-1211(90)90011-j. Epilepsy Res. 1990. PMID: 2357958

7

The efficacy and tolerability of chewable carbamazepine compared to conventional carbamazepine in patients with epilepsy.

Patsalos PN, Russell-Jones D, Finnerty G, Sander JW, Shorvon SD. Patsalos PN, et al. Among authors: sander jw. Epilepsy Res. 1990 Apr;5(3):235-9. doi: 10.1016/0920-1211(90)90044-v. Epilepsy Res. 1990. PMID: 2384079

8

Allopurinol as an add-on drug in the management of intractable epilepsy.

Sander JW, Patsalos PN. Sander JW, et al. Epilepsy Res. 1988 May-Jun;2(3):223-5. doi: 10.1016/0920-1211(88)90060-5. Epilepsy Res. 1988. PMID: 3197692

9

The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies.

Cockerell OC, Hart YM, Sander JW, Shorvon SD. Cockerell OC, et al. Among authors: sander jw. Epilepsy Res. 1994 Jul;18(3):249-60. doi: 10.1016/0920-1211(94)90045-0. Epilepsy Res. 1994. PMID: 7805646

10

The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy.

Sveinbjornsdottir S, Sander JW, Upton D, Thompson PJ, Patsalos PN, Hirt D, Emre M, Lowe D, Duncan JS. Sveinbjornsdottir S, et al. Among authors: sander jw. Epilepsy Res. 1993 Oct;16(2):165-74. doi: 10.1016/0920-1211(93)90031-2. Epilepsy Res. 1993. PMID: 8269915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

682 results

Search Page

Filters